Compare Invesco DB Oil Fund (DBO) vs Ginkgo Bioworks Holdings Inc (DNA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Invesco DB Oil Fund vs Ginkgo Bioworks Holdings Inc — how do they compare? Invesco DB Oil Fund trades at $21.06, while Ginkgo Bioworks Holdings Inc trades at $7.51 (market cap $505.73M). The key difference: Invesco DB Oil Fund is trading nearer its 52-week high, Ginkgo Bioworks Holdings Inc nearer its low. Which is the better fit depends on your goals.
| DBO | DNA | |
|---|---|---|
Sector | Commodities - Energy | Health |
52-Week High | $23.80 | $16.14 |
52-Week Low | $11.98 | $5.48 |
Market Cap | — | $505.73M |
Enterprise Value | — | $607.68M |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
DBO trades at $19.59, down 0.41% on the day, with a bearish technical signal from moving averages and oscillators showing neutrality. The stock faces resistance at $20 and support at $19. Recent news highlights oil price volatility due to Middle East tensions, particularly the Strait of Hormuz deadlock, which may impact energy sector stocks like DBO.
The outlook for DBO is cautious amid geopolitical risks and technical bearishness. Investment opportunities hinge on resolution of oil supply constraints, while risks include prolonged Middle East instability and potential earnings pressure from fluctuating crude prices. Wall Street sentiment appears mixed, with no clear consensus on near-term direction.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Invesco DB Oil Fund
DBO provides exposure to WTI crude oil prices through futures contracts. It is designed for investors seeking a way to invest in the performance of the fossil fuel market without purchasing physical oil barrels.
Read more on DBO →About Ginkgo Bioworks Holdings Inc
Ginkgo Bioworks is a leading horizontal platform for cell programming. It uses advanced automation and software to design custom organisms for customers across diverse industries, including food, agriculture, and pharma.
Read more on DNA →
